Literature DB >> 6849760

A method to prevent the loss of isoniazid and acetylisoniazid in human plasma.

A Hutchings, R D Monie, B Spragg, P A Routledge.   

Abstract

Plasma concentrations of isoniazid and N-acetylisoniazid were measured at varying times after addition of both compounds to plasma (5 micrograms/ml) and storage at several different temperatures (-70 degrees C, -20 degrees C, 4 degrees C and 20 degrees C). The concentration of both compounds declined log-linearly with time and the half-life of decline was shorter with increasing temperature of storage. Both compounds were stable for at least 5 weeks, however, when stored at -70 degrees C. We conclude that this temperature should be used to prevent loss of both compounds during storage and transport of samples.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849760      PMCID: PMC1427860          DOI: 10.1111/j.1365-2125.1983.tb01496.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  The stability of isoniazid in serum stored in the frozen state.

Authors:  J H PETERS; R C GOOD
Journal:  Am Rev Respir Dis       Date:  1962-10

2.  Deterioration of isoniazid in frozen serum samples: a confirmatory note.

Authors:  J W JENNE
Journal:  Am Rev Respir Dis       Date:  1961-06

3.  Stability of isoniazid in aqueous solutions and plasma.

Authors:  N F POOLE; A E MEYER
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

4.  The instability of isoniazid and acetylisoniazid in frozen plasma.

Authors:  D H Huffman; C A Dujovne
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-09

5.  Isoniazid dosage in patients with renal failure.

Authors:  D W Bowersox; R H Wintebauer; G L Stewart; B Orme; E Barron
Journal:  N Engl J Med       Date:  1973-07-12       Impact factor: 91.245

6.  An evaluation of the fluorometric determination of isonicotinic acid hydrazide.

Authors:  T P O'Barr; D J Keith; E B Blair
Journal:  Am Rev Respir Dis       Date:  1973-03

7.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

8.  Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.

Authors:  N Barth; G Alván; O Borgå; F Sjöqvist
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

9.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.

Authors:  P R GANGADHARAM; A L BHATIA; S RADHAKRISHNA; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

  9 in total
  8 in total

1.  Molecular genotyping of N-acetylation polymorphism to predict phenotype.

Authors:  M Mashimo; T Suzuki; M Abe; T Deguchi
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

2.  The effects of acute ethanol intake on isoniazid pharmacokinetics.

Authors:  R G Dattani; F Harry; A D Hutchings; P A Routledge
Journal:  Eur J Clin Pharmacol       Date:  2004-10-02       Impact factor: 2.953

3.  The effect of thyrotoxicosis on isoniazid acetylation.

Authors:  M D Littley; A Hutchings; B P Spragg; P A Routledge; J H Lazarus
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

4.  A simple method for determining acetylator phenotype using isoniazid.

Authors:  A Hutchings; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

5.  Effect of antacids in didanosine tablet on bioavailability of isoniazid.

Authors:  K Gallicano; J Sahai; G Zaror-Behrens; A Pakuts
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Saliva and plasma concentrations of isoniazid and acetylisoniazid in man.

Authors:  A D Hutchings; R D Monie; B P Spragg; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

7.  Drug acetylation in breast cancer.

Authors:  D J Webster; D Flook; J Jenkins; A Hutchings; P A Routledge
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

8.  N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment.

Authors:  Thuli Mthiyane; James Millard; John Adamson; Yusentha Balakrishna; Cathy Connolly; Andrew Owen; Roxana Rustomjee; Keertan Dheda; Helen McIlleron; Alexander S Pym
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.